How to Get Prolia (Denosumab) in Texas

What Is Prolia (Denosumab) and Why It Is Prescribed in Texas

Prolia is a RANK ligand inhibitor that reduces bone resorption by blocking osteoclast formation. The FDA approved denosumab 60 mg for postmenopausal osteoporosis in June 2010, and it is also indicated for men with osteoporosis, glucocorticoid-induced osteoporosis, and bone-loss associated with certain cancer therapies 1.

Texas has one of the largest populations of adults over 65 in the country. According to CDC data, an estimated 12.6% of U.S. adults aged 50 and older have osteoporosis of the femur neck or lumbar spine, and hip fractures carry a one-year mortality rate approaching 20 to 24% 2. Those numbers make early identification and treatment a genuine clinical priority for Texas providers.

The key FREEDOM trial (N=7,868 to 36 months) demonstrated that denosumab 60 mg every 6 months reduced new vertebral fractures by 68%, hip fractures by 40%, and nonvertebral fractures by 20% compared with placebo, all with P<0.001 3. That level of fracture risk reduction established denosumab as a first- or second-line option in most major guidelines. The American Association of Clinical Endocrinology 2020 clinical practice guidelines list denosumab among preferred agents for patients with high or very high fracture risk 4.

Who Can Prescribe Prolia in Texas

Any licensed Texas prescriber with DEA registration and appropriate clinical training may write a Prolia prescription. That group includes MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs).

Texas NPs operate under a collaborative practice agreement with a supervising physician for at least the first three years of independent practice 5. After that threshold is met, NPs may prescribe Schedule III-V controlled substances and non-controlled drugs, including Prolia, without a current collaborative agreement. PAs in Texas must maintain a prescriptive authority agreement with a supervising physician, but that agreement permits prescribing non-controlled medications such as denosumab 6.

Specialists who most commonly prescribe Prolia in Texas include endocrinologists, rheumatologists, gynecologists, and geriatricians. Primary care physicians prescribe a substantial share of osteoporosis medications as well. A 2021 analysis in the Journal of Bone and Mineral Research found that only 28% of eligible women with osteoporosis receive any pharmacotherapy within 12 months of a fragility fracture, which means access gaps are real and primary care prescribing remains necessary 7.

Telehealth Options for Getting a Prolia Prescription in Texas

Texas telehealth law permits synchronous video visits for new and established patients, and a Texas-licensed provider may prescribe non-controlled medications such as denosumab after a clinically sufficient evaluation 8. A phone-only visit without video or audio does not meet the Texas Medical Board's standard for establishing a valid patient-physician relationship for initial prescriptions.

For Prolia specifically, the telehealth visit covers the clinical assessment: fracture history, DEXA T-score review, medication history, and contraindication screening. The provider cannot administer the injection over video, so the patient still requires an in-person injection site. Common options include:

• A local primary care office that accepts outside prescriptions
• A Texas infusion or injection center
• A home-health nursing agency

Several national telehealth platforms hold Texas medical licenses and have added bone-health protocols in the past two years. HealthRX's own telehealth service connects Texas patients with board-certified endocrinologists and internists who review DEXA results, order labs, and submit prior authorization paperwork on the patient's behalf before the first injection date.

The Endocrine Society's 2019 Clinical Practice Guideline on osteoporosis pharmacotherapy states: "Treatment should be initiated promptly in patients with hip or vertebral fractures, T-score of -2.5 or lower, or 10-year FRAX hip fracture probability at or above 3% or major osteoporotic fracture probability at or above 20%" 9. A telehealth provider in Texas can apply that threshold and prescribe accordingly after reviewing documented DEXA results.

Required Labs and Imaging Before Your First Prolia Dose

Before prescribing denosumab, a Texas provider will review or order several specific tests. Prolia's FDA label explicitly contraindicates its use in patients with hypocalcemia; the serum calcium must be corrected before each dose 1.

Standard pre-treatment workup includes:

DEXA scan. A dual-energy X-ray absorptiometry scan of the lumbar spine and hip provides the T-score that defines osteoporosis (T-score at or below -2.5) or osteopenia (-1.0 to -2.5). Medicare covers DEXA every 24 months for qualifying beneficiaries 10.

Serum calcium. Hypocalcemia is an absolute contraindication per the FDA label. A value below 8.5 mg/dL must be corrected before injection 1.

25-hydroxyvitamin D. Severe vitamin D deficiency worsens hypocalcemia risk post-dose. Most providers target a level above 30 ng/mL before starting therapy, consistent with Endocrine Society recommendations 11.

Comprehensive metabolic panel. Renal function and liver enzymes establish a baseline, and creatinine clearance below 30 mL/min signals elevated hypocalcemia risk requiring closer monitoring 1.

FRAX calculation. The WHO Fracture Risk Assessment Tool produces a 10-year probability estimate that guides treatment thresholds. Providers can run FRAX in about 90 seconds using freely available online tools endorsed by the National Osteoporosis Foundation 12.

Dental evaluation. Osteonecrosis of the jaw (ONJ) is a rare but serious adverse event. The American Dental Association recommends completing any invasive dental procedures before initiating antiresorptive therapy 13.

Labs ordered through a telehealth provider may be sent to any LabCorp, Quest, or hospital outpatient lab in Texas. Results typically return within 24 to 72 hours, so the full pre-treatment workup rarely delays the prescription by more than one week.

How Prior Authorization Works for Prolia in Texas

Most Texas commercial insurers and Medicare Part D plans require prior authorization (PA) before approving Prolia. The PA process is the most common source of delay, often adding 1 to 3 weeks.

A complete PA submission for Prolia in Texas typically requires:

1. Documented T-score at or below -2.5 from a DEXA scan performed within the past 24 months, or a prior fragility fracture after age 50
2. Evidence of trial failure or contraindication to a bisphosphonate (most plans require at least one, such as alendronate 70 mg weekly or risedronate 35 mg weekly)
3. Normal serum calcium lab result dated within 90 days
4. ICD-10 diagnosis code (M81.0 for age-related osteoporosis without fracture; M80.00 for fracture)
5. Prescriber attestation that the patient cannot adequately absorb oral bisphosphonates due to GI conditions, or that bisphosphonate therapy caused adverse effects

A 2022 JAMA Internal Medicine analysis found that prior authorization requests for osteoporosis medications were denied at a higher rate than most other therapeutic categories, with initial denial rates near 30% for injectable agents 14. Appeals overturn roughly 40% of those denials when clinical documentation is complete. Your prescribing provider or HealthRX's patient-services team can submit the PA and manage the appeal if needed.

Texas Medicaid (STAR and traditional fee-for-service) does not cover Prolia for osteoporosis. Coverage is limited to specific oncology indications, per the Texas Medicaid preferred drug list 15. Patients covered only by Medicaid will need to explore the Amgen patient-assistance program (Amgen SupportPlus) or seek a copay card for commercial coverage.

How to Fill a Prolia Prescription at a Texas Pharmacy

Prolia requires refrigeration at 2°C to 8°C (36°F to 46°F) and cannot be dispensed like an oral medication taken home and self-administered. Most patients receive the injection through one of three channels:

Specialty pharmacy with medical-office administration. A specialty pharmacy (CVS Specialty, Walgreens Specialty, Orsini, or Diplomat) ships the drug to the provider's office or an infusion center, where a nurse administers the subcutaneous injection.

Buy-and-bill. The provider's office purchases Prolia directly from a distributor, administers the injection, and bills the patient's medical benefit (Part B for Medicare) rather than the pharmacy benefit. This approach may lower cost for Medicare beneficiaries because Medicare Part B covers Prolia at 80% of average sales price after the deductible.

Home health nursing. A licensed home-health agency in Texas dispatches a registered nurse to the patient's residence to administer the injection. The specialty pharmacy ships the drug to the home. This option suits patients with limited mobility or rural addresses.

503A compounding pharmacies in Texas are regulated by the Texas State Board of Pharmacy and cannot legally compound a biosimilar or generic version of denosumab. FDA biological product regulations prohibit compounding of approved biological reference products like Prolia under standard 503A rules 16. Patients should be cautious about any pharmacy claiming to offer "compounded denosumab" at lower cost.

A 2023 Cochrane review of denosumab versus bisphosphonates for postmenopausal osteoporosis confirmed that denosumab produced greater BMD gains at the lumbar spine (mean difference 1.87%, 95% CI 1.48 to 2.27) and total hip (mean difference 1.16%, 95% CI 0.76 to 1.56) compared with oral bisphosphonates over 12 to 24 months 17.

What to Expect at the Injection Visit and Afterward

The injection itself takes about 10 minutes. A nurse or medical assistant draws the 60 mg/mL prefilled syringe from refrigeration, allows it to reach room temperature (up to 30 minutes for comfort), then injects it subcutaneously into the upper arm, upper thigh, or abdomen.

Post-injection monitoring is minimal. The FDA label notes hypocalcemia symptoms (muscle cramps, numbness, seizures) are the primary acute concern; most providers observe patients for 15 minutes and advise them to take 1,000 to 1 to 200 mg elemental calcium and 800 to 1 to 000 IU vitamin D3 daily throughout therapy 1.

The next dose is scheduled exactly 6 months from the injection date. Missing the 6-month interval carries a specific risk that other osteoporosis drugs do not: denosumab discontinuation causes rapid bone turnover rebound, and vertebral fracture risk may increase significantly within 7 to 12 months of the last dose if no bridging therapy is started 18. Patients who stop Prolia should transition to a bisphosphonate, typically zoledronic acid 5 mg IV, within 6 months of the last Prolia injection, per a 2021 position statement from the American Society for Bone and Mineral Research 19.

Serum calcium should be rechecked 2 to 4 weeks after each injection, particularly in the first year of treatment, and 25-hydroxyvitamin D checked annually 9.

How Long the Process Takes in Texas

Most Texas patients complete the following timeline:

• Day 1: Telehealth or in-person visit; DEXA and labs ordered.
• Days 2 to 5: Lab results return. Vitamin D deficiency corrected if present.
• Days 3 to 7: Provider submits prior authorization.
• Days 7 to 21: Insurance PA approved or appealed. Specialty pharmacy coordinates shipment.
• Days 14 to 28: First injection administered.

Patients with an existing DEXA scan on file (within 24 months) and normal labs often compress this to 7 to 14 days total. Patients waiting on PA approval, especially those on Medicaid or plans with step-therapy requirements, may wait 3 to 4 weeks. A 2020 analysis in Bone found that treatment delays beyond 12 weeks after a fragility fracture were independently associated with a 45% higher risk of subsequent fracture within two years 20, underscoring the value of moving quickly once a diagnosis is established.

Transferring a Prolia Prescription to Texas

Patients relocating to Texas from another state can transfer their Prolia prescription only under specific conditions. Because Prolia is a non-controlled injectable administered in a clinical setting rather than dispensed as a take-home medication, the "transfer" is less about pharmacy-to-pharmacy transfer and more about establishing care with a Texas-licensed provider who can write a new prescription.

Steps for patients moving to Texas mid-treatment:

1. Obtain copies of your most recent DEXA report, prior-treatment records, and the date of your last injection before leaving your previous state.
2. Contact a Texas telehealth provider or specialist within 30 days of your last injection to establish care and order a new prescription.
3. Provide the date of your prior injection so the Texas provider can schedule your next dose at exactly 6 months. Missing this window risks the rebound fracture phenomenon described above.

A Texas-licensed provider may review out-of-state DEXA scans and accept them as valid documentation without requiring a repeat scan, provided the study was performed within 24 months and meets technical quality standards. DEXA scans follow standardized ISCD (International Society for Clinical Densitometry) protocols, making them portable across state lines 21.

Cost and Patient Assistance Programs in Texas

Without insurance, the wholesale acquisition cost of Prolia is approximately $1,400 to $1,600 per syringe, or $2,800 to $3,200 per year. Most patients do not pay this amount.

• Medicare Part B: Covers Prolia at 80% of average sales price after the Part B deductible. Most patients pay roughly $140 to $180 per injection after Part B cost-sharing if they have a Medigap plan.
• Commercial insurance: After PA, most plans cover Prolia under the medical or pharmacy benefit with a copay ranging from $0 to $100 per dose when an Amgen copay card is applied.
• Amgen SupportPlus: Uninsured or underinsured patients with household income below 500% of the federal poverty level may qualify for free Prolia through Amgen's patient-assistance program. Applications are submitted at amgensupportplus.com or through a provider's office.

Texas has a state pharmaceutical assistance program (Texas SHIP for Medicare beneficiaries) that may also offset Part D costs, though Prolia is more commonly billed under Part B medical benefit rather than Part D pharmacy 22.